News
Medpage Today on MSN1mon
First Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
evaluated the effect of DHEA replacement and low-dose testosterone therapy on body composition, physical performance, bone mineral density (BMD), and glucose tolerance in elderly people.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback